Healthy adults between 18 and 85 years old are needed to participate in the study of investigational COVID-19 vaccines.
The study will evaluate the safety of the vaccines and their ability to generate an immune response against COVID-19.
Financial compensation up to $1,375 is availabe for qualified participants.